Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer — Stella

Home/Urologic Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Urologic Neoplasms trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Belgium

UZ Leuven, Leuven

Netherlands

NKI-AVL, Amsterdam, North Holland

Key details

Phase

Safety & dosing

Sponsor

The Netherlands Cancer Institute

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~27 participants

Started

August 2024

Primary completion

October 2026

Age range

18 Years and older

Sex

Male only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.